Shanghai Genomics Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 93

Employees

  • Latest Deal Type
  • M&A

Shanghai Genomics General Information

Description

Developer of therapeutics for the treatment of lung diseases. The company engages in the development of bio materials, drugs and therapeutic products which are used in the treatment of lung fibrosis, hepatocirrhosis, viral infections and fractured bones.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Building 6, 230 Chuanhong Road
  • Chuansha, Pudong New Area
  • Shanghai, 201202
  • China
Primary Industry
Therapeutic Devices
Other Industries
Drug Discovery
Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • Building 6, 230 Chuanhong Road
  • Chuansha, Pudong New Area
  • Shanghai, 201202
  • China

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Shanghai Genomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 20-Jun-2005 Completed Generating Revenue
1. Early Stage VC 01-Aug-2001 Completed Startup
To view Shanghai Genomics’s complete valuation and funding history, request access »

Shanghai Genomics Patents

Shanghai Genomics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20140249347-A1 Use of pyridone derivatives in the prevention or treatment of tissue or organ toxicity induced by cytotoxic agents and radiation Inactive 15-Jun-2006
EP-2036555-A1 The use of derviate of pyridone for preventing and treating radioactive injury of lungs Active 15-Jun-2006
EP-2036555-B1 The use of pyridone derivatives for preventing and treating radiation injury of lungs Active 15-Jun-2006
EP-2036555-A4 The use of derviate of pyridone for preventing and treating radioactive injury of lungs Active 15-Jun-2006
US-20080037124-A1 Optical member and manufacturing method thereof Inactive 31-Mar-2004 G02B5/18
To view Shanghai Genomics’s complete patent history, request access »

Shanghai Genomics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Shanghai Genomics Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Shanghai Venture Capital Venture Capital Minority
Zhangjiang Group Limited Partner Minority
To view Shanghai Genomics’s complete investors history, request access »

Shanghai Genomics FAQs

  • When was Shanghai Genomics founded?

    Shanghai Genomics was founded in 2001.

  • Where is Shanghai Genomics headquartered?

    Shanghai Genomics is headquartered in Shanghai, China.

  • What is the size of Shanghai Genomics?

    Shanghai Genomics has 93 total employees.

  • What industry is Shanghai Genomics in?

    Shanghai Genomics’s primary industry is Therapeutic Devices.

  • Is Shanghai Genomics a private or public company?

    Shanghai Genomics is a Private company.

  • What is Shanghai Genomics’s current revenue?

    The current revenue for Shanghai Genomics is .

  • How much funding has Shanghai Genomics raised over time?

    Shanghai Genomics has raised $5.2M.

  • Who are Shanghai Genomics’s investors?

    Shanghai Venture Capital and Zhangjiang Group have invested in Shanghai Genomics.

  • When was Shanghai Genomics acquired?

    Shanghai Genomics was acquired on 20-Jun-2005.

  • Who acquired Shanghai Genomics?

    Shanghai Genomics was acquired by GNI Group.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »